Published online June 1, 2006
PEDIATRICS Vol. 117 No. 6 June 2006, pp. 2126-2131 (doi:10.1542/peds.2005-2621)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nimri, R.
Right arrow Articles by Phillip, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nimri, R.
Right arrow Articles by Phillip, M.
Related Collections
Right arrow Endocrinology

Insulin Pump Therapy in Youth With Type 1 Diabetes: A Retrospective Paired Study

Revital Nimri, MDa, Naomi Weintrob, MDa,b, Hadassa Benzaquen, EDa, Regina Ofan, BSNa, Gila Fayman, RDa and Moshe Phillip, MDa,b

a Institute of Endocrinology and Diabetes, National Center of Childhood Diabetes, Schneider Children's Medical Center of Israel, Petah Tiqwa, Israel
b Sackler Faculty School of Medicine, Tel Aviv University, Tel Aviv, Israel

OBJECTIVE. To compare by age and glycemic control continuous subcutaneous insulin infusion with multiple daily injections in youth with type 1 diabetes.

METHODS. The files of 279 patients who had type 1 diabetes and switched from multiple daily injections to continuous subcutaneous insulin infusion between 1998 and 2003 were reviewed for glycemic control, body mass index standard deviation score, and adverse events. Patients were divided by age as follows: 23 prepubertal (median age: 5.4; range: 1.6–8.6 years), 127 adolescent (median age: 13.7; range 9–17 years), and 129 young adult (median age: 22.8; range: 17–40 years). The data were compared between the 12 months of multiple daily injections that preceded continuous subcutaneous insulin infusion and the period after the start of continuous subcutaneous insulin infusion for the whole cohort and by age group.

RESULTS. A significant decrease in hemoglobin A1c was demonstrated after the start of continuous subcutaneous insulin infusion use for the entire cohort (–0.51%) and for the prepubertal (–0.48%), adolescent (–0.26%), and young adult (–0.76%) groups. There was a significant interaction between the change in hemoglobin A1c level and hemoglobin A1c value at initiation of pump therapy (–1.7% for patients with hemoglobin A1c ≥10%; 0.2% for patients with hemoglobin A1c ≤7%). The rate of severe hypoglycemic episodes decreased significantly in the adolescent group, from 36.5 to 11.1 events per 100 patient-years, and in the young adult group, from 58.1 to 23.3. There was no significant change in the rate of diabetic ketoacidosis between the 2 periods. The young adults showed a significant decrease in body mass index standard deviation scores (–0.08 ± 0.37).

CONCLUSIONS. Continuous subcutaneous insulin infusion improves glycemic control in youth with type 1 diabetes, especially in those with a history of poor glycemic control. This improvement is associated with a decrease in the rate of severe hypoglycemia in the absence of weight gain.

Key Words: type 1 diabetes • CSII • pumps • youth • children • adolescents

Abbreviations: CSII—continuous subcutaneous insulin infusion • MDI—multiple daily injections • HbA1c—hemoglobin A1c • SDS—standard deviation score • DKA—diabetic ketoacidosis • ANOVA—analysis of variance • DCCT—Diabetes Control and Complications Trial

Accepted Dec 14, 2005.




This article has been cited by other articles:


Home page
 Diabetes CareHome page
S. Shalitin and M. Phillip
Hypoglycemia in Type 1 Diabetes: A still unresolved problem in the era of insulin analogs and pump therapy
Diabetes Care, February 1, 2008; 31(Supplement_2): S121 - S124.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
American Diabetes Association
Standards of Medical Care in Diabetes--2008
Diabetes Care, January 1, 2008; 31(Supplement_1): S12 - S54.
[Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
T. Danne, K. Lange, and O. Kordonouri
New developments in the treatment of type 1 diabetes in children
Arch. Dis. Child., November 1, 2007; 92(11): 1015 - 1019.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
M. Phillip, T. Battelino, H. Rodriguez, T. Danne, F. Kaufman, and for the Consensus forum participants
Use of Insulin Pump Therapy in the Pediatric Age-Group: Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes
Diabetes Care, June 1, 2007; 30(6): 1653 - 1662.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
American Diabetes Association
Standards of Medical Care in Diabetes--2007
Diabetes Care, January 1, 2007; 30(suppl_1): S4 - S41.
[Full Text] [PDF]